October 18, 2021

Volume XI, Number 291

Advertisement
Advertisement

October 18, 2021

Subscribe to Latest Legal News and Analysis

Intellectual Property, Patent, Trademark and Copyright Law News

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

For hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Date Title Organization
12
Aug
Patent Owner Tip #14 for Surviving an Instituted IPR: When Not to Amend Claims in an IPR Mintz
12
Aug
Injunctive Relief Available Even Where Laches Bars Trademark Infringement, Unfair Competition Damage Claims McDermott Will & Emery
12
Aug
Second Circuit: Warhol’s “Prince Series” Derivative, Not Transformative Finnegan
12
Aug
Employee Agreement of What “Shall Be” is Future Promise, Not Present Assignment McDermott Will & Emery
12
Aug
The Skinny Label That Wasn’t—Federal Circuit Reinstates Induced Infringement Verdict McDermott Will & Emery
11
Aug
AI in Biotech and Synthetic Biology: What Can Be Protected? What Should Be Kept Secret? Mintz
11
Aug
Reminder to Professional Services Firms – Do Not Take Your Trade Secrets for Granted Sheppard, Mullin, Richter & Hampton LLP
11
Aug
How To Enforce Intellectual Property Rights in China K&L Gates
10
Aug
S.D.N.Y. Again Rejects Server Test for Display of Embedded Content Finnegan
9
Aug
Place of Business Cannot Be Imputed to Related Companies Who Maintain Corporate Separateness Finnegan
8
Aug
China Releases Draft Patent Examination Guidelines for Comment Schwegman, Lundberg & Woessner, P.A.
6
Aug
Timing is Essential for Filing Interlocutory Appeals — Do Not Wait for All Issues to be Resolved Squire Patton Boggs (US) LLP
6
Aug
Capturing All the Dimensions: Intellectual Property Protection for 3-D Designs and 3-D Printing Methods Norris McLaughlin P.A.
6
Aug
Patent Owner Tip #13 for Surviving an Instituted IPR: When to Amend Claims in an IPR Mintz
6
Aug
If You Snooze, You Lose: Prosecution Laches as a Defense by the PTO Finnegan
6
Aug
Why Obviousness-type Double Patent Analysis Isn’t Obvious Proskauer Rose LLP
5
Aug
GT Competition Currents August 2021: The Netherlands, United Kingdom, and Italy Greenberg Traurig, LLP
5
Aug
The Government's Use of Procedural Hurdles to Disallow Research Credit Refund Claims Miller Canfield
5
Aug
Federal Circuit Vacates PTAB Decisions Because the PTAB Failed to Provide Patent Owner Notice and Opportunity to Respond to Its Sua Sponte Claim Construction Finnegan
5
Aug
E-Cigarette Respondent’s Reverse Domain Name Hijacking Argument Goes Up In Smoke Finnegan

Pages

Advertisement
Advertisement